Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Antiviral Research|July 14, 2024
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19Ernna H Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2023
Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) productionEmily S Córneo, Flavio Protasio Veras, Giovanni F Gomes, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritisRaphael Sanches Peres, Foo Y Liew, Jhimmy Talbot, et al.
The Journal of Investigative Dermatology|March 15, 2023
S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 ImmunityBruno Marcel Silva de Melo, Flávio Protásio Veras, Pascale Zwicky, et al.
Biomolecules|February 26, 2025
Chikungunya Particle and RNA Induce Mechanical and Heat Hypersensitivities in a TRPV1-Dependent MannerLiziane C M da Silva, Andressa C Dos Santos Maia, Nágila C F de Sousa, et al.
Cell Reports|December 28, 2022
Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammationFlávio P Veras, Gabriel A Publio, Bruno M Melo, et al.
Cancer Immunology Research|September 9, 2022
PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive SignalingCarlos Wagner S Wanderley, Alexandre G M Maganin, Beatriz Adjafre, et al.
The Journal of Infectious Diseases|February 10, 2023
CASP4/11 Contributes to NLRP3 Activation and COVID-19 ExacerbationTamara S Rodrigues, Camila C S Caetano, Keyla S G de Sá, et al.
Science Advances|September 14, 2022
Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infectionLetícia de Almeida, Alexandre L N da Silva, Tamara S Rodrigues, et al.
Pageof 21